[1] |
WU Yujie, ZHAO Chengcheng, XI Qing.
Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033.
|
[2] |
NING Sisi, ZHAO Yuhong, YAN Lei, TANG Minna, ZHANG Ningzhi, ZHANG Yongqiao, CUI Zhaoqiang.
Controversies over the targets of controlling blood pressure in hyper- tensive patients with chronic kidney disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 463-467.
|
[3] |
SHEN Chang, AI Kelong, HU Changping.
Research progress in the regulation of hypoxic pulmonary hypertension by hypoxia-inducible factor-1 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 114-120.
|
[4] |
FU Hong, TIAN Lei.
Individualized precision therapy for patients with ischemic stroke and hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 870-876.
|
[5] |
CHEN Wengang, YIN Qin, ZHANG Weiwei, ZHOU Lulu, KOU Wanqing, YUAN Xiaolong.
Distributions of MTHFR gene polymorphism and its correlation with blood Hcy in patients with hypertension in southern Anhui province
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 768-774.
|
[6] |
GU Yifei, CHU Nannan, HUANG Kai, QUE Linling, ZHANG Jisheng, XIANG Xuemei, HE Qing.
Application and progress of pharmacodynamics study in bioequivalence evaluation of orally inhaled drug products
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 822-833.
|
[7] |
ZHANG Ningzhi, ZHAO Yuhong, TANG Minna, ZHANG Yongqiao, NING Sisi, CUI Zhaoqiang.
Application of chronopharmacology in the hypertension treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 418-422.
|
[8] |
CUI Sumei, CUI Zhaoqiang.
Application of β-blockers for hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 423-427.
|
[9] |
LI Yuanfang, CUI Zhaoqiang.
Treatment of hypertension complicated with hyperuricemia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 428-432.
|
[10] |
XU Jianfei, LIN Li.
Research progress in pharmacological and non-pharmacological treatments of hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 433-441.
|
[11] |
KUAI Zheng, ZHANG Xiaoyi, ZOU Yunzeng.
Angiotensin receptor neprilysin inhibitor in elderly with hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 442-445.
|
[12] |
LIU Guijian, CHENG Kuan, ZHU Wenqing, GE Junbo.
Progress of hypertension pharmacological treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 446-449.
|
[13] |
LI Yongliang, LIN Haiyan, ZHANG Lingling, DONG Yilong.
Effects of preoperative dezocine patient-controlled analgesia pump on stress response and cognitive function in elderly patients with lower extremity fractures
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 302-306.
|
[14] |
MENG Shi, WANG Zhongqun.
Research progress on human immunodeficiency virus-associated pulmonary arterial hypertension
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(12): 1431-1440.
|
[15] |
ZHANG Jinhua, LIU Maobai, CAI Mingzhi, ZHENG Yingli, LAO Haiyan, XIANG Qian, DU Liping, ZHU Zhu, DONG Jing, ZUO Xiaocong, LI Xingang, SHANG Dewei, CHEN Bing, YE Yanrong, WANG Yuzhu, GAO Jianjun, ZHANG Jian, CHEN Wansheng, XIE Haitang, JIAO Zheng.
Model informed precision dosing of warfarin: China expert consensus report (2022 version)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1201-1212.
|